Abstract: Provided is a rail device for a dishwasher, including a guide main body part; an upper support roller part coupled to one side of the guide main body part to be rotatable with respect to a central axis; a lower support roller part coupled to one side of the guide main body part to be rotatable with respect to a central axis; a guide rail part extendedly formed along the sliding direction with one side inserted into a space between the upper support roller part and the lower support roller part; and a rack roller part having one side inserted into the guide rail part and the other side coupled to one surface inside the main body of the dishwasher or coupled to a sliding basket.

Abstract: A method for synthesizing carbon nanotubes using a nanoparticle catalyst prepared by vaporizing a catalyst raw material using plasma and then condensing the vaporized catalyst raw material is disclosed. The production method of the present disclosure can make the synthesized carbon nanotubes have high crystallinity; and facilitate their mass synthesis.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating viral infectious diseases, containing efavirenz and fluoxetine as active ingredients. It has been identified that when a complex, mixture or combination of efavirenz and fluoxetine is administered or a complex, mixture or combination of efavirenz fluoxetine, to which a biguanide-based compound metformin is added, is administered, antiviral efficacy against various zoonotic viruses including SARS-CoV-2 is remarkably higher than when each is administered alone, and thus efavirenz and fluoxetine, in addition to the biguanide-based compound, can be effectively used as active ingredients of a composition for preventing or treating viral infectious diseases.

Abstract: An apparatus for producing carbon nanotubes includes a plasma apparatus and a CVD reactor which are connected in series is disclosed, and a nanoparticle catalyst in an aerosol state prepared in the plasma apparatus is transferred into the CVD reactor to synthesize carbon nanotubes, thereby continuously synthesizing the carbon nanotubes having excellent physical properties.

Abstract: An embodiment of the present invention provides a sliding device comprising: a first rail member of which one surface is open; a second rail member which slides on the first rail member and of which one surface is open; and one or more ball members which are disposed between the first rail member and the second rail member and are provided as seen on a cross-section, wherein the first rail member and the second rail member are arranged to be engaged with each other through the open surfaces.

Abstract: The present invention relates to an anticancer composition containing as an active ingredient a compound inducing cell senescence and apoptosis. The compound of the present invention can discriminate cancer cells and normal cells and induce both cell senescence and apoptosis in a cancer cell-specific manner. Thus, the compound does not need the attachment of any cancer cell-specific targeting substance thereto, can minimize the frequent adverse effects caused by the attack of anticancer agents on normal cells, and exhibits a potent anticancer effect on the basis of the aforementioned dual action.

Abstract: One embodiment of the present invention relates to a push-to-open device mounted on a slide device having a fixed rail and a movable rail slidably provided on the fixed rail, and provides a push-to-open device comprising: a main body mounted on the fixed rail, and having a guide path and an inner space; a slider, which is provided on the main body so as to be capable of being caught by or released from a catching member of the movable rail, and moves along the guide path; a shaft, which has one end connected to the slider and the other end connected to an elastic member provided at the main body, and has a plurality of operating protrusions protruding from the outer peripheral surface thereof and a plurality of catching protrusions protruding at positions spaced a predetermined distance from the operating protrusions in the longitudinal direction; a rotator, which is provided at the main body, and engages with the operating protrusion to rotate in one direction by means of the movement of the shaft during a p

Abstract: An embodiment of the present invention provides a pull-out system comprising: at least two slide rails each having a fixed rail, an intermediate rail slidably disposed on the fixed rail, and a moving rail slidably disposed on the intermediate rail; and a synchronization means for synchronizing movements of the respective slide rails with each other.

Abstract: An embodiment of the present invention provides a sliding device comprising: a first rail member which is open at one side surface thereof; a second rail member which slides on the first rail member and is open at one side surface thereof; and ball members which are disposed between the first rail member and the second rail member such that at least three ball members are provided as seen in a cross section, wherein the first rail member and the second rail member are arranged to be engaged with each other through the open side surfaces.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating cancer comprising an antiviral agent and an antidepressant as an active ingredient and to which a biguanide-based compound can be added, and more specifically, efavirenz, etravirine, rilpivirine, lopinavir, atazanavir, darunavir, and ritonavir as an antiviral agent, and fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, amitriptyline, clomipramine, nortriptyline, desipramine, amoxapine, maprotilline, trimipramine, protriptyline, and melithracene as an antidepressant, in complex, mixture, or combination administration, or efavirenz and fluoxetine with metformin, a biguanide compound, in complex, mixture, or combination administration, shows the significant synergistic anti-cancer activity than when each was administered alone, and so, finally the antiviral agent and antidepressant according to the present invention can be effectively used as an active ingredient in a composition for preventing or treating cancer.

Abstract: Provided is a rail device for a dishwasher, including a guide main body part; an upper support roller part coupled to one side of the guide main body part to be rotatable with respect to a central axis; a lower support roller part coupled to one side of the guide main body part to be rotatable with respect to a central axis; a guide rail part extendedly formed along the sliding direction with one side inserted into a space between the upper support roller part and the lower support roller part; and a rack roller part having one side inserted into the guide rail part and the other side coupled to one surface inside the main body of the dishwasher or coupled to a sliding basket.

Abstract: Provided herein are methods of generating optimized models of vascular grafts for subjects in certain embodiments. Methods of treating subjects in need of vascular grafts are also provided. Related systems and computer program products are additionally provided.

Abstract: Provided is an information output apparatus including one or more information output units, wherein each information output unit includes a coil arranged to be connected to a power source, such that a current flows in the coil; a base unit configured to accommodate the coil; and a driving indicator, which is arranged in the base unit to be apart from and close to the coil to be driven by a current flowing in the coil and is configured to move in a first direction toward the coil and a direction opposite thereto to rotate while being connected to the base unit and to move in a second direction crossing the first direction to be recognized by a user.

Abstract: A pharmaceutical composition for treating Gram negative bacteria-associated infections includes an antibacterial protein that includes at least one selected from the group consisting of a protein having the amino acid sequence as set forth in SEQ ID NO: 1, a protein having the amino acid sequence as set forth in SEQ ID NO: 2, a protein having the amino acid sequence as set forth in SEQ ID NO: 3, a protein having the amino acid sequence as set forth in SEQ ID NO: 4, a protein having the amino acid sequence as set forth in SEQ ID NO: 5, a protein having the amino acid sequence as set forth in SEQ ID NO: 6, a protein having the amino acid sequence as set forth in SEQ ID NO: 7, and a protein having the amino acid sequence as set forth in SEQ ID NO: 8. A method of preparing the antibacterial protein is also disclosed.

Abstract: A pharmaceutical composition for treating Gram negative bacteria-associated infections includes an antibacterial protein that includes at least one selected from the group of a protein having the amino acid sequence as set forth in SEQ ID NO: 1, a protein having the amino acid sequence as set forth in SEQ ID NO: 2, a protein having the amino acid sequence as set forth in SEQ ID NO: 3, a protein having the amino acid sequence as set forth in SEQ ID NO: 4, a protein having the amino acid sequence as set forth in SEQ ID NO: 5, a protein having the amino acid sequence as set forth in SEQ ID NO: 6, a protein having the amino acid sequence as set forth in SEQ ID NO: 7, and a protein having the amino acid sequence as set forth in SEQ ID NO: 8. A method of preparing the antibacterial protein is also disclosed.

Abstract: A pharmaceutical composition for treating Gram negative bacteria-associated infections includes an antibacterial protein that includes at least one selected from the group of a protein having the amino acid sequence as set forth in SEQ ID NO: 1, a protein having the amino acid sequence as set forth in SEQ ID NO: 2, a protein having the amino acid sequence as set forth in SEQ ID NO: 3, a protein having the amino acid sequence as set forth in SEQ ID NO: 4, a protein having the amino acid sequence as set forth in SEQ ID NO: 5, a protein having the amino acid sequence as set forth in SEQ ID NO: 6, a protein having the amino acid sequence as set forth in SEQ ID NO: 7, and a protein having the amino acid sequence as set forth in SEQ ID NO: 8. A method of preparing the antibacterial protein is also disclosed.

Abstract: The present invention relates to a pharmaceutical composition comprising trimethobenzamide or a pharmaceutically acceptable salt thereof as an active ingredient for preventing or treating neuropathy. Trimethobenzamide, when administered in combination with tramadol, exhibits the effect of significantly reducing pain in a neuropathy animal model and as such, can be advantageously used for treatment of neuropathy.

Abstract: Provided is a method for manufacturing a stent, including: coating a coating material on a stent; and drying the stent at a temperature in the range of from 40° C. to 150° C., and the coating and the drying are simultaneously performed.

Abstract: Disclosed are a pharmaceutical composition for preventing or treating a skin disease containing a purple corn extract, and more particularly, to a pharmaceutical composition for preventing or treating a skin disease containing a purple corn extract that has a potent effect of preventing or treating at least one skin disease selected from the group consisting of atopy, psoriasis, eczema, keratosis, prurigo and warts, using the purple corn extract.

Abstract: Provided is a method for manufacturing a stent, including: coating a coating material on a stent; and drying the stent at a temperature in the range of from 40° C. to 150° C., and the coating and the drying are simultaneously performed.